<DOC>
	<DOCNO>NCT02760342</DOCNO>
	<brief_summary>The objective study evaluate pharmacokinetic interaction ASP015K metformin healthy non-elderly male subject .</brief_summary>
	<brief_title>A Drug Interaction Study Evaluate Pharmacokinetics ASP015K Metformin</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Body weight screening : ≥ 50.0 kg , &lt; 80.0 kg BMI screening : ≥ 17.6 , &lt; 26.4 Subjects agree use highly effective contraception consist two form birth control ( least one must barrier method ) get inform consent 90 day final study drug administration . Subjects agree NOT donate sperm get informed consent 90 day final study drug administration . Subjects receive scheduled receive investigational drug clinical trial postmarketing study within 120 day screen test screen test hospital admission ( Day −1 ) . Subjects receive scheduled receive medication ( include overthecounter drug ) within seven day hospital admission ( Day −1 ) . Subjects receive ASP015K metformin previously . Subjects habit excessive alcohol drinking smoking . Any deviation normal range blood pressure , pulse , body temperature , 12lead ECG screen day hospital admission ( Day −1 ) . Subjects meet follow criterion laboratory test screen day hospital admission ( Day −1 ) . Normal range test specify study site test/assay organization use normal range study . Subjects complication history drug allergy . Subjects history clinically serious allergy , induces generalize urticaria anaphylactic shock require hospital admission . Subjects complication history hepatic disease , renal disease , cardiac disease , congenital short QT syndrome , respiratory disease , gastrointestinal disease . Subjects history gastrointestinal resection . Subjects develop upper gastrointestinal symptom within seven day hospital admission ( Day −1 ) . Subjects complication history endocrine disease , cerebrovascular disease , malignant tumor , lymphatic disease , lactic acidosis . Subjects apply concern regard tuberculosis . Subjects apply concern regard infection tuberculosis . Subjects vaccination live vaccine live attenuate vaccine within 56 day hospital admission ( Day −1 ) .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Metformin</keyword>
	<keyword>Drug-drug interaction</keyword>
	<keyword>ASP015K</keyword>
</DOC>